10.6084/m9.figshare.c.3644024_D3.v1 Melanie Mediavilla-Varela Melanie Mediavilla-Varela Kingsley Boateng Kingsley Boateng David Noyes David Noyes Scott Antonia Scott Antonia Additional file 3: of The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts Springer Nature 2016 Pirfenidone Cisplatin Non-small cell lung cancer Cancer associated fibroblasts 2016-03-02 05:00:00 Journal contribution https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_of_The_anti-fibrotic_agent_pirfenidone_synergizes_with_cisplatin_in_killing_tumor_cells_and_cancer-associated_fibroblasts/4467530 MTS assay showing the viability of A549 cells after 72-h treatment with a low dose of cisplatin (Cis; 10 μM) and low dose of pirfenidone (Pirf; 0.5 mg/mL) in the presence and absence of the MEK inhibitor U0126 (U; 10 μM). (PDF 3219 kb)